000163017 001__ 163017
000163017 005__ 20240229133508.0
000163017 0247_ $$2doi$$a10.1002/pst.2061
000163017 0247_ $$2pmid$$apmid:32881248
000163017 0247_ $$2ISSN$$a1539-1604
000163017 0247_ $$2ISSN$$a1539-1612
000163017 037__ $$aDKFZ-2020-01808
000163017 041__ $$aeng
000163017 082__ $$a610
000163017 1001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b0$$eLast author$$udkfz
000163017 245__ $$aComments on 'Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach' by Manuel Feißt, Johannes Krisam and Meinhard Kieser.
000163017 260__ $$aNew York, NY$$bWiley$$c2021
000163017 3367_ $$2DRIVER$$aarticle
000163017 3367_ $$2DataCite$$aOutput Types/Journal article
000163017 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611559784_13973$$xLetter
000163017 3367_ $$2BibTeX$$aARTICLE
000163017 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163017 3367_ $$00$$2EndNote$$aJournal Article
000163017 500__ $$a#LA:C060# letter lt. SCOPUS2021 Jan;20(1):196-198
000163017 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000163017 588__ $$aDataset connected to CrossRef, PubMed,
000163017 773__ $$0PERI:(DE-600)2083706-9$$a10.1002/pst.2061$$gp. pst.2061$$n1$$p196-198$$tPharmaceutical statistics$$v20$$x1539-1612$$y2021
000163017 909CO $$ooai:inrepo02.dkfz.de:163017$$pVDB
000163017 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000163017 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000163017 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000163017 9141_ $$y2021
000163017 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-02-26$$wger
000163017 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPHARM STAT : 2018$$d2020-02-26
000163017 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-02-26
000163017 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000163017 980__ $$ajournal
000163017 980__ $$aVDB
000163017 980__ $$aI:(DE-He78)C060-20160331
000163017 980__ $$aUNRESTRICTED